Gastrointestinal Microbiome Clinical Trial
Official title:
The Effect of Micronutrient Supplementation on Gut Microbiome Composition and Function
The main aim of this randomized crossover study is to explore the effect of micronutrient supplementation on gut microbiota composition and function in healthy volunteers. Participants will undertake two 10-day trials with a replicated diet separated by a 15-day washout period. For one of these trials, participants will take a daily over-the-counter multivitamin supplement. Faecal and urine samples will be collected at the start and end of each trial to assess changes in gut microbiota composition, urinary and faecal metabolomics, and targeted bacterial metabolites including short chain fatty acids, sulphide, and lactate.
Exploring the effect of habitual dietary patterns on human gut microbiota and on host health is an area of scientific interest and a major funding theme in UKRI. The main aim of this proof-of-concept study is to explore the effect of micronutrient supplementation on gut microbiota composition and function in healthy volunteers. Participants will be asked to undertake two trials with 15 day washout in-between. If the participants are allocated to the "supplementation group" they will be asked to consume an over-the-counter multivitamin supplement for 10 days (1 tablet per day) in addition to their usual diet. Participants will provide faecal and urinary samples prior to initiation of the intervention and again at the end of the 10-day supplementation. During these 10 days participants will be asked to record the meals they consume on provided food diaries. If the participants are allocated to the "control group", participants will be asked to provide the same number of samples and at the same intervals as the supplementation group (i.e. at baseline and after 10 days) but without receiving micronutrient supplementation. Participants will also be asked to replicate as close as possible the diet they had followed during the first trial they were allocated. Between the two trials, participants will follow a wash-out period of 15 days with the aim of reverting the gut microbiota characteristics back to baseline levels. The main outcome measures of this study are to assess changes in gut microbiota composition based on 16S rRNA gene amplicon sequencing, changes in urinary/faecal metabolomics, and changes in targeted bacterial metabolites (short chain fatty acids, sulphide, lactate). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05961189 -
Influence of Short-Term Antibiotic Therapy on Exercise
|
Early Phase 1 | |
Not yet recruiting |
NCT06126094 -
Benefits of Alcoholic Hangover Medicine
|
N/A | |
Completed |
NCT06087146 -
Modulation of the Gut Microbiota of Professional Athletes With Sauerkraut Supplementation
|
N/A | |
Not yet recruiting |
NCT05364736 -
Effect of Prebiotics on Blood Pressure Management
|
N/A | |
Completed |
NCT03949543 -
The Timing of Main Meal Consumption Effect on Gut Microbiota and Host
|
N/A | |
Recruiting |
NCT05636670 -
Assessment of Cognitive Function and Gut Microbiota Analysis in Real World Patients With Lupus Cerebrovascular Disease
|
||
Completed |
NCT02998177 -
Characterization of Rebound Pain Following Peripheral Nerve Block and Its Association With Gut Microbiome Diversity
|
N/A | |
Recruiting |
NCT05657730 -
Study the Effect of Water Kefir Consumption on the Gut Microbiome in Healthy Adults
|
N/A | |
Active, not recruiting |
NCT03978104 -
Impact of Okara and Bio-okara Food Product on Gut and Glycaemic Health in Middle-aged and Older Adults in Singapore
|
N/A | |
Terminated |
NCT04059666 -
Gastrointestinal Tract Microbiome in Healthy Term Infants Receiving Mother'S-own Breast Milk or Cow's Milk-based Infant Formulas
|
N/A | |
Completed |
NCT04088474 -
Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora
|
N/A | |
Not yet recruiting |
NCT06332898 -
The Effects of a Nutritional Supplement on Nutrient Status and Quality of Life
|
N/A | |
Completed |
NCT04046432 -
Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora, Peristalsis, Immunity, and Anti-oxidative Capacity
|
N/A | |
Completed |
NCT05729269 -
Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass
|
||
Recruiting |
NCT05692024 -
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06207136 -
Microbiome and Diet in Parkinson's Disease
|
N/A | |
Recruiting |
NCT03812445 -
Cognition and Gut Microbiome Associated Study of Shanghai People With Acute Ischemic Stroke
|
N/A | |
Not yet recruiting |
NCT04947930 -
Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population
|
||
Completed |
NCT02867605 -
Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health
|
N/A | |
Recruiting |
NCT04031469 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
|